Submit Manuscript  

Article Details


New Therapeutic Targets and Drugs for the Treatment of Asthma

[ Vol. 18 , Issue. 8 ]

Author(s):

Mateus Feitosa Alves*, Diogo Vilar da Fonseca, Silvia Adelaide Linhares de Melo, Marcus Tullius Scotti, Luciana Scotti, Socrates Golzio dos Santos and Margareth de Fatima Formiga Melo Diniz   Pages 684 - 696 ( 13 )

Abstract:


Asthma is an inflammatory disease which affects millions of people worldwide. Therefore, it is necessary to search for new sources of therapies for the treatment of these patients in order to improve their quality of life. From content analysis of literature of new therapeutic targets, there are various targets and drugs reported to be promising for the treatment of asthma. Interleukins involved in inflammatory processes are often presented as candidate targets for new drugs. The action of such therapeutics would not only affect interleukins, but also their receptors. Small molecules (e.g. ligustrazine and SP600125) and large molecule antibodies (e.g. lebrikizumab, benralizumab, dupilumab) are being considered as novel agents for the pharmacotherapy of asthma. Therefore, through this research, we can see advances in the search for new targets and promising drugs to treat asthma. It is expected that these new drug candidates will eventually be approved and marketed so that asthma patients can use them to enhance their quality of life.

Keywords:

Asthma, drugs, monoclonal antibody, natural products, targets, therapeutic targets.

Affiliation:

Postgraduate Program in Natural Products and Synthetic Bioactive, Federal University of Paraiba, Joao Pessoa - PB, Federal University of Sao Francisco Valley, Juazeiro-BA, Postgraduate Program in Development and Technological Innovation in Medicines, Federal University of Paraiba, Joao Pessoa - PB, Postgraduate Program in Natural Products and Synthetic Bioactive, Federal University of Paraiba, Joao Pessoa - PB, Postgraduate Program in Natural Products and Synthetic Bioactive, Federal University of Paraiba, Joao Pessoa - PB, Research Institute for Drugs and Medicines, Federal University of Paraiba, Joao Pessoa - PB, Postgraduate Program in Natural Products and Synthetic Bioactive, Federal University of Paraiba, Joao Pessoa - PB

Graphical Abstract:



Read Full-Text article